Sonoco Implementing Price Increases for All Rigid Paperboard Containers in North America
Mar 20, 2017 10:45 am UTC| Business
HARTSVILLE, S.C., March 20, 2017 -- Sonoco (NYSE:SON) today announced it is implementing price increases for all round composite cans and shaped rigid paperboard containers in North America by a minimum of 5 percent....
Gazit Globe Provides Further Update on First Capital Realty, Inc. (“FCR”) Share Sale
Mar 20, 2017 10:35 am UTC| Business
TEL AVIV, Israel, March 20, 2017 -- Gazit-Globe (NYSE:GZT) (TSX:GZT) (TASE:GZT), a leading global real estate company focused on the ownership, development and management of supermarket-anchored shopping centers in...
Two New Publications Highlight the Potential for MultiStem® Treatment of Ischemic Stroke
Mar 20, 2017 10:30 am UTC| Business
CLEVELAND, March 20, 2017 -- Athersys, Inc. (NASDAQ:ATHX) announced today that clinical investigators have published results from Athersys’ Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients...
Mar 20, 2017 10:00 am UTC| Business
LAS VEGAS, March 20, 2017 -- XLI Technologies, Inc. (OTC PINK:XLIT) (the “Company” or “XLI”) is proud to announce the continuation of the Printed LightSheet Fixture installations which originally began on May 13, 2016...
Global Brokerage, Inc. Announces Fourth Quarter 2016 Results
Mar 20, 2017 10:00 am UTC| Business
Fourth Quarter 2016 Highlights Updates: U.S. GAAP net revenues from continuing operations of $80.6 millionU.S. GAAP net income attributable to Global Brokerage, Inc. from continuing operations of $10.7 million or $1.91...
AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results
Mar 20, 2017 10:00 am UTC| Business
ALBANY, N.Y., March 20, 2017 -- AngioDynamics(NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it...
NeuroRx to Present at the Oppenheimer Annual Healthcare Conference on March 21st
Mar 20, 2017 10:00 am UTC| Business
Wilmington, Delaware , March 20, 2017 -- NeuroRx, a clinical stage biopharma company developing the first oral therapy for Acute Suicidal Ideation and Behavior (ASIB), today announced that Jonathan Javitt, M.D., M.P.H.,...